Symbols / HCTI Stock $2.19 -2.67% Healthcare Triangle, Inc.

Healthcare • Health Information Services • United States • NCM
HCTI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO —
Exch · Country NCM · United States
Market Cap 4.31M
Enterprise Value 14.82M
Income -9.48M
Sales 13.89M
FCF (ttm) -13.06M
Book/sh 17.67
Cash/sh 3.88
Employees 43
Insider 10d —
IPO Oct 13, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.17
PEG —
P/S 0.31
P/B 0.12
P/C —
EV/EBITDA -1.63
EV/Sales 1.07
Quick Ratio 0.76
Current Ratio 1.03
Debt/Eq 107.97
LT Debt/Eq —
EPS (ttm) -152.30
EPS next Y -13.20
EPS Growth —
Revenue Growth 43.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-15
Earnings (prior) 2026-04-15
ROA -49.55%
ROE -3.92%
ROIC —
Gross Margin 13.61%
Oper. Margin -141.54%
Profit Margin -68.22%
Shs Outstand 1.97M
Shs Float 1.97M
Insider Own 0.01%
Instit Own 0.74%
Short Float 9.10%
Short Ratio 0.25
Short Interest 179.03K
52W High 7,470.00
vs 52W High -99.97%
52W Low 2.10
vs 52W Low 4.29%
Beta 1.16
Impl. Vol. —
Rel Volume 0.20
Avg Volume 740.06K
Volume 151.53K
Target (mean) $5.00
Tgt Median $5.00
Tgt Low $5.00
Tgt High $5.00
# Analysts 1
Recom Strong_buy
Prev Close $2.25
Price $2.19
Change -2.67%
About

Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations; Blockchain; and Cybersecurity navigator. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, the company offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery capabilities on public cloud. It also serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. The company was incorporated in 2019 and is based in Pleasanton, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.00
Mean price target
2. Current target
$2.19
Latest analyst target
3. DCF / Fair value
$-119.49
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.19
Low
$5.00
High
$5.00
Mean
$5.00
News
RSS: Latest HCTI news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
13.89
+18.77%
11.70
-64.77%
33.20
-27.64%
45.89
Operating Revenue
13.89
+18.77%
11.70
-64.77%
33.20
-27.64%
45.89
Cost Of Revenue
12.00
+36.28%
8.81
-66.68%
26.43
-23.60%
34.59
Reconciled Cost Of Revenue
12.00
+36.28%
8.81
-66.68%
26.43
-23.60%
34.59
Gross Profit
1.89
-34.60%
2.89
-57.36%
6.78
-40.00%
11.29
Operating Expense
11.66
+56.10%
7.47
-41.46%
12.76
-45.11%
23.25
Research And Development
0.54
+24.94%
0.43
-46.31%
0.80
-90.18%
8.14
Selling General And Administration
10.42
+69.36%
6.15
-40.82%
10.40
-14.58%
12.17
Selling And Marketing Expense
3.08
+39.99%
2.20
-52.83%
4.67
-29.77%
6.65
General And Administrative Expense
7.34
+85.75%
3.95
-31.03%
5.73
+3.71%
5.52
Other Gand A
7.34
+85.75%
3.95
-31.03%
5.73
+3.71%
5.52
Total Expenses
23.66
+45.38%
16.28
-58.46%
39.19
-32.25%
57.84
Operating Income
-9.77
-113.32%
-4.58
+23.46%
-5.99
+49.95%
-11.96
Total Operating Income As Reported
-9.79
-106.04%
-4.75
+38.26%
-7.70
+52.86%
-16.32
EBITDA
-8.20
-112.81%
-3.85
+36.98%
-6.12
+42.82%
-10.70
Normalized EBITDA
-8.17
-121.68%
-3.69
+16.38%
-4.41
+51.11%
-9.02
Reconciled Depreciation
0.70
-20.70%
0.89
-43.23%
1.57
-46.77%
2.94
EBIT
-8.91
-87.80%
-4.74
+38.25%
-7.68
+43.67%
-13.64
Total Unusual Items
-0.04
+79.41%
-0.17
+90.06%
-1.71
-1.60%
-1.68
Total Unusual Items Excluding Goodwill
-0.04
+79.41%
-0.17
+90.06%
-1.71
-1.60%
-1.68
Special Income Charges
-0.02
+90.00%
-0.17
+90.06%
-1.71
-1.60%
-1.68
Other Special Charges
—
—
-0.01
+98.89%
-1.08
Impairment Of Capital Assets
—
0.00
-100.00%
1.71
-60.83%
4.37
Restructuring And Mergern Acquisition
—
—
0.00
+100.00%
-1.60
Write Off
0.02
-90.00%
0.17
0.00
—
Net Income
-9.48
-58.75%
-5.97
+31.28%
-8.69
+39.50%
-14.36
Pretax Income
-9.48
-59.07%
-5.96
+31.14%
-8.65
+37.55%
-13.85
Net Non Operating Interest Income Expense
-0.57
+53.26%
-1.21
-25.31%
-0.97
-356.60%
-0.21
Interest Expense Non Operating
0.57
-53.26%
1.21
+25.31%
0.97
+356.60%
0.21
Net Interest Income
-0.57
+53.26%
-1.21
-25.31%
-0.97
-356.60%
-0.21
Interest Expense
0.57
-53.26%
1.21
+25.31%
0.97
+356.60%
0.21
Other Income Expense
0.86
+629.45%
-0.16
+90.40%
-1.70
-0.89%
-1.68
Other Non Operating Income Expenses
0.90
+12728.57%
0.01
-41.67%
0.01
—
Gain On Sale Of Security
-0.02
—
—
—
Tax Provision
0.00
-100.00%
0.01
-65.71%
0.04
-93.08%
0.51
Tax Rate For Calcs
0.00
-100.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
+100.00%
-0.04
0.00
0.00
Net Income Including Noncontrolling Interests
-9.48
-58.75%
-5.97
+31.28%
-8.69
+39.50%
-14.36
Net Income From Continuing Operation Net Minority Interest
-9.48
-58.75%
-5.97
+31.28%
-8.69
+39.50%
-14.36
Net Income From Continuing And Discontinued Operation
-9.48
-58.75%
-5.97
+31.28%
-8.69
+39.50%
-14.36
Net Income Continuous Operations
-9.48
-58.75%
-5.97
+31.28%
-8.69
+39.50%
-14.36
Normalized Income
-9.44
-61.81%
-5.83
+16.36%
-6.98
+44.96%
-12.68
Net Income Common Stockholders
-9.48
-58.75%
-5.97
+31.28%
-8.69
+39.50%
-14.36
Diluted EPS
—
-15,749.34
+47.78%
-30,159.72
+41.39%
-51,462.37
Basic EPS
—
-15,749.34
+47.78%
-30,159.72
+41.39%
-51,462.37
Basic Average Shares
—
0.00
+31.60%
0.00
+3.23%
0.00
Diluted Average Shares
—
0.00
+31.60%
0.00
+3.23%
0.00
Diluted NI Availto Com Stockholders
-9.48
-58.75%
-5.97
+31.28%
-8.69
+39.50%
-14.36
Depreciation Amortization Depletion Income Statement
0.70
-20.70%
0.89
-43.23%
1.57
-46.77%
2.94
Depreciation And Amortization In Income Statement
0.70
-20.70%
0.89
-43.23%
1.57
-46.77%
2.94
Line Item Trend 2023-12-31
Total Assets
6.86
Current Assets
5.65
Cash Cash Equivalents And Short Term Investments
1.23
Cash And Cash Equivalents
1.23
Receivables
3.60
Accounts Receivable
3.60
Gross Accounts Receivable
3.60
Allowance For Doubtful Accounts Receivable
0.00
Prepaid Assets
—
Other Current Assets
0.82
Total Non Current Assets
1.21
Net PPE
0.04
Gross PPE
0.13
Accumulated Depreciation
-0.09
Machinery Furniture Equipment
0.13
Other Properties
—
Goodwill And Other Intangible Assets
0.86
Goodwill
0.00
Other Intangible Assets
0.86
Non Current Accounts Receivable
0.30
Total Liabilities Net Minority Interest
8.25
Current Liabilities
8.15
Payables And Accrued Expenses
1.95
Payables
1.95
Accounts Payable
1.95
Other Payable
—
Current Accrued Expenses
—
Current Debt And Capital Lease Obligation
3.79
Current Debt
3.79
Other Current Borrowings
1.11
Current Capital Lease Obligation
0.00
Other Current Liabilities
2.41
Total Non Current Liabilities Net Minority Interest
0.10
Long Term Debt And Capital Lease Obligation
0.10
Long Term Debt
0.10
Other Non Current Liabilities
0.50
Stockholders Equity
-1.39
Common Stock Equity
-1.39
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
0.00
Ordinary Shares Number
0.00
Treasury Shares Number
0.00
Additional Paid In Capital
26.21
Retained Earnings
-27.60
Minority Interest
—
Total Equity Gross Minority Interest
-1.39
Total Capitalization
-1.29
Working Capital
-2.50
Invested Capital
2.49
Total Debt
3.88
Net Debt
2.65
Capital Lease Obligations
0.00
Net Tangible Assets
-2.25
Tangible Book Value
-2.25
Duefrom Related Parties Non Current
0.30
Line Of Credit
2.68
Preferred Shares Number
—
Preferred Stock Equity
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-16.52
-1428.49%
-1.08
+49.74%
-2.15
+59.82%
-5.35
Cash Flow From Continuing Operating Activities
-16.52
-1428.49%
-1.08
+49.74%
-2.15
+59.82%
-5.35
Net Income From Continuing Operations
-9.48
-58.75%
-5.97
+31.28%
-8.69
+39.50%
-14.36
Depreciation Amortization Depletion
0.70
-20.70%
0.89
-43.23%
1.57
-46.77%
2.94
Depreciation And Amortization
0.70
-20.70%
0.89
-43.23%
1.57
-46.77%
2.94
Other Non Cash Items
0.50
-52.57%
1.05
+993.75%
0.10
+106.63%
-1.45
Stock Based Compensation
0.45
+418.39%
0.09
-47.59%
0.17
-35.41%
0.26
Asset Impairment Charge
0.02
-90.00%
0.17
-90.06%
1.71
-62.73%
4.59
Operating Gains Losses
-0.03
—
—
-1.08
Gain Loss On Investment Securities
—
—
—
—
Net Foreign Currency Exchange Gain Loss
-0.03
0.00
—
—
Change In Working Capital
-8.69
-422.85%
2.69
-10.18%
3.00
-20.04%
3.75
Change In Receivables
-4.24
-299.91%
2.12
-30.22%
3.04
-8.57%
3.33
Changes In Account Receivables
-0.91
-139.44%
2.31
+1.98%
2.27
-36.68%
3.58
Change In Payables And Accrued Expense
-1.49
-350.93%
0.59
+22.52%
0.48
+223.47%
-0.39
Change In Other Current Assets
-3.13
-722.71%
0.50
+6375.00%
-0.01
+98.24%
-0.45
Change In Other Current Liabilities
0.17
+131.43%
-0.53
-0.96%
-0.52
-141.01%
1.27
Investing Cash Flow
-1.75
0.00
+100.00%
-0.01
+98.94%
-1.13
Cash Flow From Continuing Investing Activities
-1.75
0.00
+100.00%
-0.01
+98.94%
-1.13
Net PPE Purchase And Sale
-0.01
0.00
+100.00%
-0.01
+70.00%
-0.04
Purchase Of PPE
-0.01
0.00
—
—
Capital Expenditure
-1.50
—
-0.01
+98.94%
-1.13
Net Business Purchase And Sale
—
—
0.00
0.00
Purchase Of Business
—
—
0.00
0.00
Net Intangibles Purchase And Sale
-1.50
0.00
0.00
+100.00%
-1.09
Purchase Of Intangibles
-1.50
0.00
0.00
+100.00%
-1.09
Net Other Investing Changes
-0.25
—
—
—
Financing Cash Flow
25.88
+19557.89%
-0.13
-106.47%
2.06
-66.06%
6.06
Cash Flow From Continuing Financing Activities
25.88
+19557.89%
-0.13
-106.47%
2.06
-66.06%
6.06
Net Issuance Payments Of Debt
9.41
+964.46%
-1.09
-169.99%
1.56
+451.77%
0.28
Issuance Of Debt
—
—
0.00
0.00
Repayment Of Debt
—
—
0.00
+100.00%
-0.19
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
—
—
0.00
+100.00%
-0.19
Net Long Term Debt Issuance
—
—
0.00
+100.00%
-0.19
Net Short Term Debt Issuance
9.41
+964.46%
-1.09
-169.99%
1.56
+226.89%
0.48
Net Common Stock Issuance
—
—
0.50
-91.30%
5.75
Common Stock Payments
—
—
0.00
+100.00%
-0.14
Cash Dividends Paid
0.00
0.00
—
—
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-0.14
Proceeds From Stock Option Exercised
—
—
0.00
-100.00%
0.03
Net Other Financing Charges
17.03
+1681.59%
0.96
+91.20%
0.50
+270.07%
-0.29
Changes In Cash
7.61
+726.44%
-1.21
-1034.58%
-0.11
+75.06%
-0.43
Beginning Cash Position
0.02
-98.38%
1.23
-7.98%
1.34
-24.24%
1.77
End Cash Position
7.62
+38025.00%
0.02
-98.38%
1.23
-7.98%
1.34
Free Cash Flow
-18.03
-1567.62%
-1.08
+50.02%
-2.16
+66.66%
-6.49
Interest Paid Supplemental Data
0.00
-100.00%
0.12
-87.50%
0.97
+356.60%
0.21
Income Tax Paid Supplemental Data
0.00
-100.00%
0.01
-65.71%
0.04
-90.20%
0.36
Common Stock Issuance
—
—
0.50
-91.51%
5.89
Interest Paid CFF
-0.57
0.00
—
—
Issuance Of Capital Stock
—
—
0.50
-91.51%
5.89
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category